Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil®): Experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancerEleni Andreopoulou, Franco M. Muggia, D. Mirchandani et al.|Annals of Oncology|2007Cited by 83
Feasibility and Cardiac Safety of Pegylated Liposomal Doxorubicin plus Trastuzumab in Heavily Pretreated Patients with Recurrent HER2-Overexpressing Metastatic Breast CancerEleni Andreopoulou, Franco M. Muggia, Darci Gaiotti et al.|Clinical Breast Cancer|2007Cited by 31